Target intelligence / Profile preview

Protein transport protein Sec61 subunit alpha isoform 2 (SEC61A2)

Target
SEC61A2
Molecular classification
Transporter (Sec61 translocon family), Channel (ER protein-conducting channel), ER membrane protein complex
01

Overview

Protein transport protein Sec61 subunit alpha isoform 2 (SEC61A2) is a core component of the SEC61 channel-forming translocon complex within the endoplasmic reticulum (ER)[1][9][10]. This complex mediates the **translocation of signal peptide–containing precursor polypeptides** across the ER membrane—an essential, conserved process in protein biosynthesis and membrane assembly[2][3][6]. SEC61A2, alongside its paralog SEC61A1, forms the protein-conducting channel with the capacity to function as a major **ribosome receptor and a gated pore**, enabling both co- and post-translational import of polypeptides into the ER[1][2][7]. The channel also provides a route for passive calcium ion (Ca²⁺) leakage from the ER, influencing cellular calcium homeostasis[2]. SEC61A2's role is particularly critical in pancreatic β-cells, where it impacts proinsulin biosynthesis and thereby glucose regulation[5]. Dysfunction of SEC61A2—by mutation, suppression, or pharmacologic inhibition—has been linked to congenital neutropenia, diabetes, and cancer pathogenesis, making it a potential therapeutic target, though safety concerns are extensive given its central cellular function[2][5].

Other names
SEC61A2Sec61 translocon subunit alpha 2Sec61 alpha-2FLJ10578protein transport protein Sec61 subunit alpha isoform 2Sec61 alpha 2 subunitSec61 alpha form 2sec61 alpha-2
02

Mechanism of action

Inhibition of protein translocation by blocking the Sec61 channel function (prevents passage of nascent polypeptides into ER, impairs secretory pathway proteins) Disruption of ER calcium homeostasis via Ca²⁺ leak

03

Biological functions

Cotranslational translocation of nascent polypeptides across ER membraneRibosome receptor for protein insertionPassive calcium (Ca²⁺) leak channel of ERAssembly of membrane and secretory proteinsSignal peptide recognitionProtein folding and post-translational modification via interaction with accessory complexes (TRAP, TRAM, OST, EMC)
04

Disease associations

Diabetes (linked via impact on proinsulin biosynthesis)Autosomal dominant severe congenital neutropeniaCancer (mutations, amplification, overexpression associated with tumor pathogenesis)Genetic diseases (caused by Sec61 point mutations/gating dysfunction)
05

Safety considerations

Inhibiting SEC61 translocon function may impair biosynthesis of many essential secretory and membrane proteins, raising risks of cytotoxicity and organ dysfunctionBlockade may disrupt ER calcium signaling and trigger ER stress/unfolded protein response, with broad cell viability consequencesImmunosuppression and metabolic disorders are theoretical risks due to its central role in protein trafficking
06

Interacting drugs

Sec61 inhibitors (small molecules developed to block function, primarily in cancer models)

1 more in the full profile.

07

Biomarkers

SEC61A2 deficiency or mutation status (potentially for diabetes risk/insulin biosynthesis dysfunction)Genetic mutations for congenital neutropeniaOverexpression/amplification status in certain cancers (experimental biomarker utility)

Beyond the preview

Go deeper on Protein transport protein Sec61 subunit alpha isoform 2 (SEC61A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein transport protein Sec61 subunit alpha isoform 2 (SEC61A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call